10.10.19
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, has developed a new label-cap combination that protects the integrity of original medicine containers, helping to prevent illegal reuse through clear, irreversible first-opening indication.
At CPhI Worldwide in Frankfurt, November 5-7, the company will present Flexi-Cap Prime, the latest addition to its Flexi-Cap portfolio of security solutions offering even higher degrees of safety.
Empty medicine containers with original labels can be filled with ineffective or harmful substitutes and reintroduced into the market by counterfeiters, posing risks to patients and challenges to pharmaceutical manufacturers. To help counteract this, a special feature of Flexi-Cap Prime is its complex construction, including a tear strip running through both the film cap and the label. When the tear strip is opened at the starter tab, it simultaneously destroys the cap and the label so that undetected reuse of the container is no longer possible.
Like all products in the Flexi-Cap family, Flexi-Cap Prime can easily be integrated into a pharmaceutical manufacturer’s production processes. It is also applied without heat, and can be flexibly adapted to diverse container types, shapes and sizes while the label’s design and the pharma manufacturer’s brand appearance remain unchanged. The integration of additional features, such as counterfeiting protection elements, offers further opportunities for securing the supply chain.
For healthcare staff, the newly developed Flexi-Cap Prime ensures the integrity of the vial until its final application. Flexi-Cap Prime is easy to use and enables fast and efficient first-opening verification. Thus, patients can be protected against the administration of ineffective and potentially harmful medications.
At CPhI Worldwide in Frankfurt, November 5-7, the company will present Flexi-Cap Prime, the latest addition to its Flexi-Cap portfolio of security solutions offering even higher degrees of safety.
Empty medicine containers with original labels can be filled with ineffective or harmful substitutes and reintroduced into the market by counterfeiters, posing risks to patients and challenges to pharmaceutical manufacturers. To help counteract this, a special feature of Flexi-Cap Prime is its complex construction, including a tear strip running through both the film cap and the label. When the tear strip is opened at the starter tab, it simultaneously destroys the cap and the label so that undetected reuse of the container is no longer possible.
Like all products in the Flexi-Cap family, Flexi-Cap Prime can easily be integrated into a pharmaceutical manufacturer’s production processes. It is also applied without heat, and can be flexibly adapted to diverse container types, shapes and sizes while the label’s design and the pharma manufacturer’s brand appearance remain unchanged. The integration of additional features, such as counterfeiting protection elements, offers further opportunities for securing the supply chain.
For healthcare staff, the newly developed Flexi-Cap Prime ensures the integrity of the vial until its final application. Flexi-Cap Prime is easy to use and enables fast and efficient first-opening verification. Thus, patients can be protected against the administration of ineffective and potentially harmful medications.
